| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | -0.22 | 0.2 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.2 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.2 |